Modulation of AML-blasts with clinically approved response modifiers to leukemia-derived dendritic cells (DCleu) ex vivo: DC-, T-cell- and cytokine profiles are predictive for antileukemic T-cell reactivity
Titel:
Modulation of AML-blasts with clinically approved response modifiers to leukemia-derived dendritic cells (DCleu) ex vivo: DC-, T-cell- and cytokine profiles are predictive for antileukemic T-cell reactivity
Auteur:
Fischer, Z. Deen, D. Hirn, A. Plett, C. Kugler, C. Rabe, A. Liepert, A. Freudenreich, M. Kraemer, D. Schmid, C. Schmetzer, H.M.